Real-time enrollment status for this metastatic pancreatic adenocarcinoma clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:47 AM UTC
| NCT Number | NCT07226856 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Pancreatic Adenocarcinoma |
| Phase | PHASE2 |
| Target Enrollment | 43 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Mayo Clinic |
| Last Updated on CT.gov | June 9, 2026 (Jun 9, 2026) |
As of August 28, 2026: Clinical trial NCT07226856 is currently recruiting participants. This phase2 study for metastatic pancreatic adenocarcinoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Mayo Clinic. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07226856 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07226856 was last updated Jun 9, 2026 (June 9, 2026). HelloStudys verifies this status automatically.